Related Experiment Video
Updated: Aug 16, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Mechanistic approaches to chemoprevention of mutation and cancer
Lynnette R Ferguson1, Giorgio Bronzetti, Silvio De Flora
1The University of Auckland, School of Medical Sciences, Faculty of Medical and Health Sciences, Discipline of Nutrition/ACSRC, Private Bag 92019, Auckland 1000, New Zealand.
Abstract:
This is the eighth special issue of 'Mutation Research' to focus on antimutagenesis and anticarcinogenesis. It covers a wide range of mechanisms from prevention of cancer initiation by antimutagens through to inhibition of tumour angiogenesis and selective estrogen receptor modulators. New screening methods and new biomarkers are also elucidated. There is increasing reason to believe that the long-term use of a combination of anticarcinogens, over an extended time span, may provide a realistic prospect of reducing the current burden of human cancers.
Insights
This special issue explores antimutagenesis and anticarcinogenesis, focusing on preventing cancer initiation and progression. Combining anticarcinogens may offer a realistic strategy to reduce the global burden of human cancers.
Area of Science:
- Biomedical Sciences
- Cancer Research
- Molecular Biology
Background:
- This issue focuses on antimutagenesis and anticarcinogenesis, addressing cancer prevention and treatment.
- It reviews mechanisms including cancer initiation prevention, tumor angiogenesis inhibition, and selective estrogen receptor modulators.
Discussion:
- The role of antimutagens in preventing cancer initiation is examined.
- Mechanisms involving tumor angiogenesis inhibition and selective estrogen receptor modulators are discussed.
- New screening methods and biomarkers for cancer prevention are elucidated.
Key Insights:
- Antimutagens can prevent cancer initiation through various mechanisms.
- Inhibiting tumor angiogenesis and using selective estrogen receptor modulators are potential anticarcinogenic strategies.
- Novel screening methods and biomarkers are crucial for advancing cancer prevention research.
Outlook:
- Long-term combination therapy with anticarcinogens shows promise for reducing cancer incidence.
- Further research into these mechanisms could lead to effective cancer prevention strategies.
- The development of new biomarkers will aid in early detection and personalized prevention.
More Related Videos
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Mutagenicity and Carcinogenicity
Spontaneous and Induced Mutations
Cancer Prevention
Some...
Cancer
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair